News for 'pharmaceutical'

As domestic sales decline, drug makers focus on exports

As domestic sales decline, drug makers focus on exports

Rediff.com1 Oct 2020

While sales in the domestic market declined 4.2 per cent during the April-July period, exports grew steadily at 9.5 per cent during the same period.

Johnson & Johnson's single-dose COVID vaccine gets approval in India

Johnson & Johnson's single-dose COVID vaccine gets approval in India

Rediff.com7 Aug 2021

"India expands its vaccine basket! Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against COVID-19," tweeted the minister.

Lupin sells Japan arm to Unison for Rs 3,702 cr

Lupin sells Japan arm to Unison for Rs 3,702 cr

Rediff.com12 Nov 2019

The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India.

Indian pharma exports report double-digit growth after 3 yrs

Indian pharma exports report double-digit growth after 3 yrs

Rediff.com3 May 2019

The only category of pharmaceuticals that showed a negative growth in exports this time was herbal products, exports of which stood at $299 million as compared to $ 312 million in the previous year.

Beware! New COVID-19 variant with high spike mutations detected in South Africa

Beware! New COVID-19 variant with high spike mutations detected in South Africa

Rediff.com25 Nov 2021

The South African authorities said the detected cases and percentage of people testing positive are both increasing quickly, particularly in particularly in most populated province of Gauteng, North West and Limpopo regions of the country.

Cabinet nod for trade pact with Mauritius covering 310 items

Cabinet nod for trade pact with Mauritius covering 310 items

Rediff.com17 Feb 2021

The Union Cabinet on Wednesday approved the signing of a comprehensive economic cooperation agreement, a kind of a free trade pact, between India and Mauritius which is aimed at liberalising norms to boost two-way commerce

Regulator asks traders to stock 55 ICU drugs

Regulator asks traders to stock 55 ICU drugs

Rediff.com18 Apr 2020

This is apart from the requirement to stock hydroxychloroquine (200 mg) and Azithromycin (500 mg) tablets for patients requiring ICU management, asymptomatic healthcare workers and asymptomatic household contacts of positive cases.

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

Oxford/AstraZeneca COVID-19 vaccine approved by UK regulator

Rediff.com30 Dec 2020

The UK's National Health Service was already lining up thousands of medics and volunteers to be ready to deliver jabs up and down the country.

PE/VC investments drop 51% to $4.1 billion as big deals shrink in July

PE/VC investments drop 51% to $4.1 billion as big deals shrink in July

Rediff.com14 Aug 2020

According to the IVCA-EY report, July recorded 10 large deals worth $3.1 billion compared to 13 large deals worth $7.1 billion in July 2019.

India raises withdrawal of students' visas with US

India raises withdrawal of students' visas with US

Rediff.com8 Jul 2020

It is understood that India's border row with China figured in the talks between Foreign Secretary Harsh Vardhan Shringla and US Under Secretary of State for Political Affairs David Hale though there was no mention of it in the press statements issued by the two sides.

Help people, take their feedback: PM to Union ministers

Help people, take their feedback: PM to Union ministers

Rediff.com30 Apr 2021

Sources said the pandemic and the response of the government is likely to be discussed in the virtual meet.

'Large-caps, especially with a value bias, are preferable at this stage'

'Large-caps, especially with a value bias, are preferable at this stage'

Rediff.com7 Jan 2022

'If the third wave of Covid infections is as bad as the second one, the market may get very polarised with a preference for blue-chips with low volatility.'

Infra, small-cap, and PSU funds top one-year performance charts

Infra, small-cap, and PSU funds top one-year performance charts

Rediff.com15 Nov 2021

The one-year returns for equity-oriented mutual fund (MFs) schemes have largely mirrored the gains made in the secondary market. However, schemes that invest in infrastructure (infra), small-cap, and public sector undertaking (PSU) banks have emerged standout performers, with gains in excess of 100 per cent in some cases. Of the total 484 equity schemes, 353 have managed to beat the Sensex, reveals the data provided by Value Research. Around 20 have delivered returns in excess of 90 per cent and six schemes have given returns of over 100 per cent in the past one year. The S&P BSE Sensex Total Return Index (TRI) has given returns of 51 per cent in the last one year, ended October 29.

IPO frenzy continues; 2 public issues to open on Sep 1

IPO frenzy continues; 2 public issues to open on Sep 1

Rediff.com29 Aug 2021

The IPO rush will continue in September with two more companies Vijaya Diagnostic Centre and Ami Organics launching their initial share-sales on Wednesday to raise a total of Rs 2,465 crore. This comes after eight companies including Devyani International, Nuvoco Vistas Corporation and CarTrade Tech floated their initial share-sales last month to mobilise Rs 18,243 crore. So far in the current fiscal, a total of 20 companies have mopped up more than Rs 45,000 crore through IPOs. This is much higher than Rs 31,277 crore raised by 30 firms in the entire 2020-21.

Bilateral trade: No direct impact of Russia-Ukraine crisis on India

Bilateral trade: No direct impact of Russia-Ukraine crisis on India

Rediff.com25 Feb 2022

There is no direct impact of the Russia-Ukraine crisis on India in terms of bilateral trade but a surge in oil prices poses considerable risk to the economy, an analyst report said on Friday. International oil prices which have surged past $100 per barrel "pose risks to external stability and currency movement," a Bank of Baroda Economics Research report said. Russia has launched military operations against Ukraine, stoking fears of significant disruption in the region, including loss of life. The West is ramping up financial sanctions against Russia and support for Ukraine.

ASK AJIT: Stocks To Buy, Hold, Sell

ASK AJIT: Stocks To Buy, Hold, Sell

Rediff.com11 Mar 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.

Court rejects Mamta Kulkarni's plea to de-freeze bank accounts

Court rejects Mamta Kulkarni's plea to de-freeze bank accounts

Rediff.com3 Aug 2021

On April 14, 2016, the crime branch of the Thane police had seized over 20 tonnes of ephedrine and 2.5 tonnes of acetic anhydride drugs from a pharmaceutical factory - Avon Life Sciences - in Solapur and other locations in Thane and Ahmedabad.

PM chairs all-party meeting on COVID-19 situation

PM chairs all-party meeting on COVID-19 situation

Rediff.com4 Dec 2020

This will be the second all-party meeting called by the government to discuss the COVID-19 situation since the outbreak of the pandemic.

India Inc cutting employee costs as coronavirus hurts recovery

India Inc cutting employee costs as coronavirus hurts recovery

Rediff.com19 Aug 2020

June indicates a change in trend from previous quarters in terms of how much companies are spending on employees. The worst hit sectors included steel, air transport service and automobile firms.

The bizarre tale of Cairn retro tax

The bizarre tale of Cairn retro tax

Rediff.com6 Mar 2022

The levy of retrospective tax on the UK's Cairn Energy Plc is a tale of bizarre twists and turns that saw its attached shares being sold in May 2018 amid the passing of the baton from a full-time finance minister to interim one and the talks at the highest level to resolve the dispute, to claims that levy of back taxes was a result of an investigation into Panama Papers leak. The government late last month refunded about Rs 7,900 crore it had collected from selling residual shares of the British firm in its erstwhile India unit, seizing dividend and withholding tax refunds, to settle an eight-year-old dispute that had tarred the country's reputation as an investment destination. But, this did not come about easily. For seven years, the establishment vehemently justified in courts and outside seeking of Rs 10,247 crore in back taxes plus interest and penalty from a firm that gave India its biggest onshore oil discovery.

Masks, hand sanitiser declared 'essential commodities'

Masks, hand sanitiser declared 'essential commodities'

Rediff.com14 Mar 2020

These items will remain under essential commodities segment till June-end, a move aimed at ensuring availability at reasonable prices and cracking down on hoarders/black marketeers.

Exports jump 58.23% to $34 bn in March

Exports jump 58.23% to $34 bn in March

Rediff.com1 Apr 2021

The country's exports jumped by 58.23 per cent to $34 billion in March as key sectors such as engineering, gems and jewellery and pharmaceuticals recorded healthy growth rate during the month, according to the Commerce Ministry's provisional data. Exports during April-March 2020-21, however, dipped by 7.4 per cent to $290.18 billion compared to $313.36 billion in 2019-20, the data showed. Imports during 2020-21 contracted by 18 per cent to $388.92 billion compared to $474.71 billion during 2019-20. In March 2020, the exports stood at $21.49 billion, which was a decline of about 34 per cent over March 2019 due to global slowdown induced by the Covid-19 crisis.

Govt in talks with Pfizer, J&J for supply of vaccines to India

Govt in talks with Pfizer, J&J for supply of vaccines to India

Rediff.com2 Jun 2021

The central government is importing COVID-19 vaccines and is in talks with COVID-19 vaccine manufacturers Pfizer and Johnson & Johnson, Union Minister of State for Home Affairs G Kishan Reddy said.

Serum to supply 22cr Covishield doses to Centre in October

Serum to supply 22cr Covishield doses to Centre in October

Rediff.com21 Sep 2021

The Serum Institute of India has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Union government has announced resuming export of surplus Covid vaccines in the coming fourth quarter under the 'Vaccine Maitri' programme, official sources said.

India has 100 unicorns valued at $240bn, bulk of them in Bengaluru

India has 100 unicorns valued at $240bn, bulk of them in Bengaluru

Rediff.com23 Mar 2021

These unicorns, or startups valued at over USD 1 billion, are across industries, beyond technology and tech-enabled sectors as well, like pharmaceuticals, and consumer goods, Credit Suisse India equity strategist Neelkanth Mishra told reporters in Mumbai.

Pfizer, Moderna won't sell Covid vaccines to Delhi: CM

Pfizer, Moderna won't sell Covid vaccines to Delhi: CM

Rediff.com24 May 2021

Pfizer and Moderna said they won't give us vaccine and will directly talk to the Centre," Kejriwal told reporters.

Govt developing multi-variant Covid-19 vaccine

Govt developing multi-variant Covid-19 vaccine

Rediff.com14 Sep 2021

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus, reports Sohini Das.

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga

'We have to do everything to avoid a super spreader event'

'We have to do everything to avoid a super spreader event'

Rediff.com1 Jan 2022

'Health will continue to be at the centre of the government's attention as it underpins economic recovery and our collective well being.'

'Every company wants to recruit people'

'Every company wants to recruit people'

Rediff.com10 Nov 2021

'There was hardly any recruitment after the second wave.' 'Now, there is a huge demand for manpower.'

September 1st week exports jump 13.35%, imports down 21.37%

September 1st week exports jump 13.35%, imports down 21.37%

Rediff.com10 Sep 2020

India's exports during the first week of September jumped 13.35 per cent year-on-year to $ 6.12 billion, official data released on Thursday showed. At the same time, imports declined by 21.37 per cent to $ 6.85 billion. Consequently, the deficit during September 1 to 7 worked out to $ 730 million.

Retro Tax: Cairn drops lawsuits in US, UK

Retro Tax: Cairn drops lawsuits in US, UK

Rediff.com26 Dec 2021

Britain's Cairn Energy Plc has dropped lawsuits against the Indian government and its entities in the US and other places and is in the final stages of withdrawing cases in Paris and the Netherlands to get back about Rs 7,900 crore that were collected from it to enforce a retrospective tax demand. As part of the settlement reached with the government to the seven-year old dispute over levy of back taxes, the company - which is now known as Capricorn Energy PLC - has initiated proceedings to withdraw lawsuits it had filed in several jurisdictions to enforce an international arbitration award which had overturned levy of Rs 10,247 crore retrospective taxes and ordered India to refund the money already collected. Two sources with direct knowledge of the matter said Cairn on November 26 withdrew the lawsuit it had brought in Mauritius for recognition of the arbitration award and took similar measures in courts in Singapore, the UK and Canada.

HDFC Bank ex-CEO Aditya Puri joins Carlyle as senior advisor

HDFC Bank ex-CEO Aditya Puri joins Carlyle as senior advisor

Rediff.com2 Nov 2020

Former HDFC Bank CEO Aditya Puri will be guiding global Carlyle on investment opportunities across Asia as a senior advisor, the global private equity major said on Monday.

SII to raise monthly production to 10 cr doses by Aug, Bharat Biotech promises 7.8 cr

SII to raise monthly production to 10 cr doses by Aug, Bharat Biotech promises 7.8 cr

Rediff.com12 May 2021

Several states and UTs including Delhi, Maharashtra, Karnataka and Telangana have decided to opt for global tenders for procurement of anti-coronavirus shots with the domestic supply falling short to meet the rising demand.

'Sputnik V provides immunity for a longer duration'

'Sputnik V provides immunity for a longer duration'

Rediff.com26 Jul 2021

'Its efficacy is 97.6 per cent.'

Why 1,700 employees of Pfizer's India arm may lose their jobs

Why 1,700 employees of Pfizer's India arm may lose their jobs

Rediff.com10 Jan 2019

A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.

Trump has not been tested for coronavirus: White House

Trump has not been tested for coronavirus: White House

Rediff.com10 Mar 2020

Trump was in contact with multiple lawmakers who have since gone into self-imposed quarantine.

ASK AJIT: How to get 20% return on shares?

ASK AJIT: How to get 20% return on shares?

Rediff.com17 Dec 2021

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

Stocks You Must AVOID or EXIT

Stocks You Must AVOID or EXIT

Rediff.com26 Apr 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.